1. A multicenter, open‐label phase II study of recombinant CPT (Circularly Permuted TRAIL) plus thalidomide in patients with relapsed and refractory multiple myeloma. Issue 11 (29th September 2014) Authors: Geng, Chuanying; Hou, Jian; Zhao, Yaozhong; Ke, Xiaoyan; Wang, Zhao; Qiu, Lugui; Xi, Hao; Wang, Fuxu; Wei, Na; Liu, Yan; Yang, Shifang; Wei, Peng; Zheng, Xiangjun; Huang, Zhongxia; Zhu, Bing; Chen, Wen‐Ming Journal: American journal of hematology Issue: Volume 89:Issue 11(2014:Nov.) Page Start: 1037 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Phase1b Dose Escalation Study of Recombinant Circularly Permuted TRAIL in Patients With Relapsed or Refractory Multiple Myeloma. (October 2018) Authors: Hou, Jian; Qiu, Lugui; Zhao, Yaozhong; Zhang, Xuejun; Liu, Yan; Wang, Zhao; Zhou, Fang; Leng, Yun; Yang, Shifang; Xi, Hao; Wang, Fuxu; Zhu, Bing; Chen, Wenming; Wei, Peng; Zheng, Xiangjun Journal: American journal of clinical oncology Issue: Volume 41:Number 10(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MHCRoBERTa: pan-specific peptide–MHC class I binding prediction through transfer learning with label-agnostic protein sequences. Issue 3 (21st April 2022) Authors: Wang, Fuxu; Wang, Haoyan; Wang, Lizhuang; Lu, Haoyu; Qiu, Shizheng; Zang, Tianyi; Zhang, Xinjun; Hu, Yang Journal: Briefings in bioinformatics Issue: Volume 23:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Rituximab for acute demyelinating myelopathy after allogeneic hematopoietic stem cell transplantation: a case report. Issue 5 (3rd July 2020) Authors: Xing, Lina; Wen, Shupeng; Niu, Zhiyun; Wang, Fuxu; Zhang, Xuejun Journal: Postgraduate medicine Issue: Volume 132:Issue 5(2020) Page Start: 485 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Rituximab for acute demyelinating myelopathy after allogeneic hematopoietic stem cell transplantation: a case report. Issue 5 (3rd July 2020) Authors: Xing, Lina; Wen, Shupeng; Niu, Zhiyun; Wang, Fuxu; Zhang, Xuejun Journal: Postgraduate medicine Issue: Volume 132:Issue 5(2020) Page Start: 485 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗